Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

License to Cure: Greed, Politics & Medical Licensure in the U.S.

Philip Seo, MD, MHS  |  Issue: October 2022  |  October 7, 2022

From Flexner’s point of view, this made perfect sense. At the time, the majority of medical schools were private institutions that were mainly interested in earning money. They were not a neutral or reliable arbiter of medical proficiency. Given that physician qualifications were a matter of public interest, the state seemed to be the natural guardian against quacks and charlatans.15

Although some states had introduced physician licensure previously, the Flexner Report made state licensure standard. Thus, in addition to reforms in medical education, the Flexner Report fueled the widespread adoption of a disjointed system in which each state sets its own standards for granting physicians a license to practice medicine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Medical license reciprocity is the practice of granting physicians in one state the right to practice medicine in another state. You’ve never heard of this courtesy because, by and large, it doesn’t exist—except in Michigan. The Michigan Board of Medicine will grant the right to practice to any physician who has had an active license for at least a decade anywhere in the U.S. or Canada.16 Before the pandemic, no other state routinely granted this courtesy.

The New Mexico Medical Board allows licensure by endorsement, in which board-certified physicians who have been licensed and in practice in another state for at least three years can apply for a medical license without resubmitting proof of education or training.17 Endorsement is not the same as reciprocity; it’s just a shortcut. The candidate still needs to pay the licensure fee.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
In addition to reforms in medical education, the Flexner Report fueled the widespread adoption of a disjointed system in which each state sets its own standards for granting physicians a license to practice medicine.

Now we come to the real reason that states have clung to this antiquated system of medical licensure. When you wonder why there is no national license to practice medicine, an obvious answer is profit.

The average cost of initial medical licensure for an MD in the U.S. (including a background check, where required) is $458. In five states, the cost of initial medical licensure is over $1,000; in 28 states, it is at least $500.18 Nationwide, just granting medical licenses to physicians generates well over $200 million in total state revenue annually.

There is also a less obvious answer: competition. Controlling who can practice medicine allows the state to control competition. Physicians who live in a given state can be protected from having to compete with physicians from neighboring states. Because it is difficult for physicians to practice across state lines, a physician who earns money in a given state is more likely to spend (and pay taxes) on that money in that same state. State legislators have no particular incentive to increase competition for the physicians who voted them into office.

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:OpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:Dr. William Oslermedical licensetelemedicine

Related Articles
    anaken2012/shutterstock.com

    Legalities of Telemedicine

    October 15, 2015

    A brief has been filed with the U.S. Supreme Court that, if the court decides to hear the case, could have wide-ranging implications for online medical care and the limits of a physician’s First Amendment right to free speech. Medical Advice Via e-Mail Institute for Justice Senior Attorney Jeff Rowes filed the brief at the…

    60 Days to a Reciprocal Medical License in Nevada

    October 14, 2015

    A new law in Nevada streamlines medical licensure for physicians and could help rheumatologist recruitment efforts…

    Attracting More Medical Students to Rheumatology

    Attracting More Medical Students to Rheumatology

    October 13, 2015

    Updated Oct. 22, 2015 (revised to delete inaccurate statistics) The cold, hard facts: This year’s rheumatology fellowship applicant pool resembles those of prior years. It is extremely diverse; every continent is represented, save Antarctica. It is somewhat larger, due in part to the growing influx of graduates from the cluster of Caribbean-based medical schools, where…

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences